Saturday, September 25, 2010 5:29:10 PM
Do you get away with handing in your football picks on Monday too 
?
I don't follow the company that closely but I would bet on positive results too. They have seemed to be one of the few (small) oncology companies that has had consistent successes and monocolonals seem to (still) be a promising technology plus it doesn't hurt to have Bill Gates blessing.
I don't know about refractory Hodgkins being what they are ultimately shooting for. I'm guessing they want to move to front-line and other indications. But then again, if they get Allos type of pricing maybe 2nd line Hodgkins is a big enough market for them.
? I don't follow the company that closely but I would bet on positive results too. They have seemed to be one of the few (small) oncology companies that has had consistent successes and monocolonals seem to (still) be a promising technology plus it doesn't hurt to have Bill Gates blessing.
I don't know about refractory Hodgkins being what they are ultimately shooting for. I'm guessing they want to move to front-line and other indications. But then again, if they get Allos type of pricing maybe 2nd line Hodgkins is a big enough market for them.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
